首页 | 本学科首页   官方微博 | 高级检索  
     


CSF myelin basic protein in multiple sclerosis
Authors:A. J. Thomson  J. Brazil  C. Feighery  A. Whelan  J. Kellet  E. A. Martin  M. Hutchinson
Affiliation:Department of Neurology, St. Vincent's and Adelaide Hospitals and;Department of Immunology, St. James's Hospital, Dublin, Ireland
Abstract:Cerebrospinal fluid (CSF) from 221 patients with multiple sclerosis (MS) and 85 patients with other neurological disorders (OND) was examined using a competitive radioimmunoassay for myelin basic protein (MBP) immunoreactivity. MBP was found in 46 of 55 MS patients (84%) examined within six weeks of relapse but in only 11 of 85 patients (13%) with OND. There was a significant correlation between the concentration of MBP in the CSF and relapse severity in patients seen within four weeks of the onset of symptoms (p less than 0.01). Of 44 patients in remission, MBP was detected in 12, and these patients had a significantly higher tendency to subsequent relapse (p less than 0.05). In 72 patients with progressive disease the presence of MBP in the CSF reflected the confidence of clinical diagnosis. The results of this study suggest that measurement of MBP in the CSF gives an objective method of monitoring disease activity in patient with MS.
Keywords:Cerebrospinal fluid    multiple sclerosis    myelin basic protein    radioimmunoassay
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号